Brink Therapeutics is a venture-backed biotech company specializing in the development of cutting-edge gene therapy tools. We focus on site-specific recombinases, highly efficient enzymes that enable precise DNA modifications - such as inserting, removing, or inverting DNA sequences - without causing double-strand breaks. These recombinases offer a safer, more precise alternative to existing technologies like CRISPR-Cas9, giving them the potential to revolutionize Cell and Gene Therapies and finally push them over the brink of mass accessibility.
By joining Brink Therapeutics, you will become part of a passionate and growing team at an exciting inflection point - with meaningful progress behind us and significant momentum ahead as we advance toward our Series A. Together, we are building an ambitious company harnessing advanced Directed Evolution, deep gene-mining techniques and AI to unlock new possibilities for treating & curing cancers, genetic disorders and beyond.
If you are an innovative scientist or engineer excited about working together to solve hard, longstanding problems to improve patients’ lives around the world, we are looking for passionate individuals to join our team and help shape the future of medicine!
Mission Highlights
As a Scientist, Molecular Biology, you will be responsible for helping expand and execute our advanced in vitro droplet-based recombinase Directed Evolution platform, with the ultimate goals of generating and characterizing in vitro lead recombinase enzyme candidates of high therapeutic utility and generating massive NGS datasets for computational colleagues to extract learnings from.
Responsibilities
Develop & execute processes for the design and generation of ultra-large, smart recombinase variant libraries (in collaboration with computational scientists)
Develop & execute in vitro droplet-based recombinase Directed Evolution assays starting from our existing platform (microfluidics expertise not required)
Develop & execute NGS-based processes for efficient readout of Directed Evolution assays
Develop & execute in vitro assays for the rapid characterization of key recombinase functional and biochemical properties
Communicate project status, requirements, risks and mitigation to stakeholders
Perform critical data analysis (with computational scientist support as needed), maintain detailed electronic laboratory records, present results to stakeholders
Disclose research innovations to internal stakeholders to secure IP protection
Competencies
You feel at home in the wet lab, designing experiments and generating & interpreting data. You enjoy communicating your findings in a clear and actionable manner, particularly to fellow scientists in both the wet and dry lab. You are conscious of maximizing the value of your research activities by employing good documentation practices. You are a sharp and collaborative trouble-shooter who doesn’t shy away from the hard problems.
Required:
MSc with 2+ years of experience or PhD in molecular biology, biochemistry or related fields, and eagerness to keep learning
Proven record of innovative problem-solving skills
Demonstrated expertise in experimental design, assay development and data analysis
Excellent written and oral communication
English - professional working proficiency
Motivation to work in a flexible and fast-paced startup
The ideal candidate will also have some of the following:
Experience working in fast-paced startup environments
Expertise in Directed Evolution, gene library synthesis, and NGS
Expertise in recombinase enzymology
Recruitment Process
We first check that your profile meets our requirements
An introductory call with one of the founders
Technical and value-fit interviews with wider team, on-site
Why join us?
Unique opportunity to be part of an early-stage biotech company, shaping the future of genome editing for Cell and Gene Therapy
Competitive salary + benefits package
Beautiful, well-equipped offices & labs in the heart of Paris, filled with great plants and great people
If you're excited about helping revolutionize genome editing and opening up Cell & Gene Therapy to the millions who could benefit, apply now, and let's make the difference together!

At Breega, we back world-class founders for the future. We’re not simple investors - we’re entrepreneurs who’ve built, scaled, and learned what it really takes to grow.
Our forte is not just writing checks: it’s rolling up our sleeves - with our Scaling Squad, our portfolio companies get hands-on expertise in hiring, sales, marketing and strategy so they don’t just expand, they dominate.
We partner with outliers rewriting the rules of Digital, Climate, and Deep Tech from pre-Seed to Series A+ across Europe and Africa.
Since 2015, we’ve grown to €700M AUM, with main offices in London and Paris and deep roots in the most thriving tech hubs across both continents, as well as a portfolio of 110+ bold startups—Exotec, Alice & Bob, Moneybox, 011H, etc—each pushing the boundaries of what’s possible.
Certified BCorp